The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
The Regulatory Working Group will kick off an all-year-long survey on Regulatory Intelligence to learn from members the latest practices of local & overseas regulators that may bring systemic impact […]
More than 260 members attended the Code of Practice Train-the-Trainer Workshop on 11 January 2023 to understand the key changes of the Code and its implications for HKAPI members.
We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.
HKAPI is pleased to announce that Mr. Howard Lin has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 6th September 2022.
The 1st CEO Meeting of the Term (2022-24) was held online on 11 July 2022. More than 20 CEOs and directors from our member companies joined to meet the new HKAPI Board, and exchanged views on the future directions of the Association.
The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.
Dear member, At the beginning of the year of Tiger, the HKAPI organizes an intensive class on Thrive with Energy Programme for improving the personal well-being of members. With the […]